{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T19:06:52Z","timestamp":1781204812258,"version":"3.54.1"},"reference-count":30,"publisher":"AOSIS","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>As breast cancer incidence increases and survival improves, an increasing number of breast cancer survivors (BCS) require long-term follow-up and support. Primary care providers play a central role in maintaining continuity of care, promoting endocrine therapy adherence, managing complications such as lymphoedema and supporting psychosocial well-being. This article aims to provide a structured approach to breast cancer survivorship care, aligned with national cancer care policies and guidelines and international best practices, focused on primary care integration. A case vignette aims to bridge theory and practice, contextualise decision-making and encourage patient-centred care as it relates to breast cancer survivorship in the South African context.<\/jats:p>","DOI":"10.4102\/safp.v68i1.6200","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T01:32:07Z","timestamp":1768267927000},"update-policy":"https:\/\/doi.org\/10.4102\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Breast cancer survivorship in South Africa: A holistic primary care approach"],"prefix":"10.4102","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9476-7867","authenticated-orcid":false,"given":"Mareike","family":"Rabe","sequence":"first","affiliation":[{"name":"Vita Oncology, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6362-8870","authenticated-orcid":false,"given":"Nita M.","family":"Robinson","sequence":"additional","affiliation":[{"name":"Vita Oncology, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2580","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Dlamini Z, Molefi T, Khanyile R, et al. From incidence to intervention: A comprehensive look at breast cancer in South Africa. Oncol Ther. 2024;12(1):1\u201311. https:\/\/doi.org\/10.1007\/s40487-023-00248-1","DOI":"10.1007\/s40487-023-00248-1"},{"key":"ref1","unstructured":"Debbie @CANSA. Breast cancer [homepage on the Internet]. CANSA \u2013 The Cancer Association of South Africa; 2022 [cited 2025 Jun 30]. Available from: https:\/\/cansa.org.za\/breast-cancer\/"},{"key":"ref2","unstructured":"Cancer in South Africa (2008\u20132019) [homepage on the Internet]. Statistics South Africa; 2023 [cited 2025 Jun 30]. Available from: https:\/\/www.statssa.gov.za\/publications\/03-08-00\/03-08-002023.pdf"},{"key":"ref3","unstructured":"Herbst M. CANSA fact sheet on breast cancer in men [homepage on the Internet]. CANSA; 2024 [cited 2025 Jul 20]. Available from: https:\/\/cansa.org.za\/files\/2024\/10\/CANSA-Fact-Sheet-on-Breast-Cancer-in-Men-NCR-2022-web-October-2024.pdf"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Abboah-Offei M, Bayuo J, Salifu Y, Afolabi O, Akudjedu TN. Experiences and perceptions of men following breast cancer diagnosis: A mixed method systematic review. BMC Cancer. 2024;24(1):179. https:\/\/doi.org\/10.1186\/s12885-024-11911-9","DOI":"10.1186\/s12885-024-11911-9"},{"key":"ref5","unstructured":"Definition of survivorship \u2013 NCI dictionary of cancer terms [homepage on the Internet]. NCI; 2011 [cited 2025 Jun 30]. Available from: https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/survivorship"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Mollica MA, Doose M, Reed C, Tonorezos E. Defining concepts in cancer survivorship. Cancer. 2025;131(16):e70039. https:\/\/doi.org\/10.1002\/cncr.70039","DOI":"10.1002\/cncr.70039"},{"key":"ref7","unstructured":"National Department of Health. Clinical guidelines for breast cancer control and management. Pretoria: National Department of Health; 2018."},{"key":"ref8","unstructured":"National cancer strategic framework 2017\u20132022 [homepage on the Internet]. National Department of Health; 2017 [cited 2025 Sept 14]. Available from: https:\/\/knowledgehub.health.gov.za\/system\/files\/elibdownloads\/2023-04\/national-cancer-strategic-framework-2017-2022-min.pdf"},{"key":"ref9","unstructured":"What do PMBs cover for breast cancer? [homepage on the Internet]. Council for Medical Schemes; 2024 [cited 2025 Sept 14]. Available from: https:\/\/www.medicalschemes.co.za\/what-do-pmbs-cover-for-breast-cancer\/"},{"key":"ref10","unstructured":"National Comprehensive Cancer Network (NCCN). Clinical practice guidelines in oncology, breast cancer [homepage on the Internet]. 2025 [cited 2025 Sept 22]. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf"},{"key":"ref11","unstructured":"Icon medicine formulary [homepage on the Internet]. 2025 [cited 2025 Aug 30]. Available from: https:\/\/iconsa.co.za\/wp-content\/uploads\/2025\/07\/Icon-Medicine-Formulary-July-2025.pdf"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Khatcheressian JL, Hurley P, Bantug E, et al. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(7):961\u2013965. https:\/\/doi.org\/10.1200\/JCO.2012.45.9859","DOI":"10.1200\/JCO.2012.45.9859"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Dix-Peek T, Dickens C, Augustine T, et al. FGFR2 genetic variants in women with breast cancer. Mol Med Rep. 2023;28(6):226. https:\/\/doi.org\/10.3892\/mmr.2023.13113","DOI":"10.3892\/mmr.2023.13113"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"De Lima H, Ramos S, Rajkumar L, Cubasch H. Female breast cancer trends: A South African perspective. S Afr J Radiol. 2025;29(1):a3117. https:\/\/doi.org\/10.4102\/sajr.v29i1.3117","DOI":"10.4102\/sajr.v29i1.3117"},{"key":"ref15","unstructured":"Tamoxifen [homepage on the Internet]. [cited 2025 Jul 20]. Available from: https:\/\/go.drugbank.com\/drugs\/DB00675"},{"key":"ref16","unstructured":"Breast cancer prevention: Aromatase inhibitors [homepage on the Internet]. [cited 2025 Jul 20]. Available from: https:\/\/www.cancer.org\/cancer\/types\/breast-cancer\/risk-and-prevention\/aromatase-inhibitors-for-lowering-breast-cancer-risk.html"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Ying Z, Linxun L, Kechang Z, Xiaowu W, Huazhen G, Zhijun M. Optimal extension time after initial endocrine therapy for postmenopausal hormone receptor-positive early-stage breast cancer: A systematic review and meta-analysis. BMC Womens Health. 2025;25(1):156. https:\/\/doi.org\/10.1186\/s12905-025-03610-9","DOI":"10.1186\/s12905-025-03610-9"},{"key":"ref18","unstructured":"Sisler J, Chaput G, Sussman J, Ozokwelu E. Follow-up after treatment for breast cancer practical guide to survivorship care for family physicians. Can Fam Physician. 2016;62:805\u2013811."},{"key":"ref19","unstructured":"Trastuzumab [homepage on the Internet]. [cited 2025 Jul 20]. Available from: https:\/\/go.drugbank.com\/drugs\/DB00072"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Dickens C, Duarte R, Zietsman A, et al. Racial comparison of receptor-defined breast cancer in Southern African women: Subtype prevalence and age-incidence analysis of nationwide cancer registry data. Cancer Epidemiol Biomarkers Prev Publ. 2014;23(11):2311\u20132321. https:\/\/doi.org\/10.1158\/1055-9965.EPI-14-0603","DOI":"10.1158\/1055-9965.EPI-14-0603"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Wiseman RJ, Riddin J, Jugathpal J, Parrish AJ, Ruff P, Blockman M. Adjuvant trastuzumab in early HER2-positive breast cancer: Journeying towards the optimal duration of therapy in South Africa. S Afr Med J. 2020;110(4):271. https:\/\/doi.org\/10.7196\/SAMJ.2020.v110i4.14621","DOI":"10.7196\/SAMJ.2020.v110i4.14621"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Earl HM, Hiller L, Vallier AL, et al. 6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial. Lancet. 2019;393(10191):2599\u20132612. https:\/\/doi.org\/10.1016\/S0140-6736(19)30650-6","DOI":"10.1016\/S0140-6736(19)30650-6"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Nardin S, Mora E, Varughese FM, et al. Breast cancer survivorship, quality of life, and late toxicities. Front Oncol. 2020;10:864. https:\/\/doi.org\/10.3389\/fonc.2020.00864","DOI":"10.3389\/fonc.2020.00864"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: A systematic review and meta-analysis. Lancet Oncol. 2013;14(6):500\u2013515. https:\/\/doi.org\/10.1016\/S1470-2045(13)70076-7","DOI":"10.1016\/S1470-2045(13)70076-7"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Marco CM, Pillay R, Schoonheim C. The management of breast cancer-related lymphoedema. S Afr Med J. 2014;104(5):382. https:\/\/doi.org\/10.7196\/SAMJ.8251","DOI":"10.7196\/SAMJ.8251"},{"key":"ref26","unstructured":"Find a therapist [homepage on the Internet]. Lymphoedema Association of South Africa; 2024 [cited 2025 Sept 22]. Available from: https:\/\/www.laosa.co.za\/find-a-therapist\/"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Silver JK, Baima J, Mayer RS. Impairment-driven cancer rehabilitation: An essential component of quality care and survivorship. CA Cancer J Clin. 2013;63(5):295\u2013317. https:\/\/doi.org\/10.3322\/caac.21186","DOI":"10.3322\/caac.21186"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Beste ME, Kaunitz AM, McKinney JA, Sanchez-Ramos L. Vaginal estrogen use in breast cancer survivors: A systematic review and meta-analysis of recurrence and mortality risks. Am J Obstet Gynecol. 2025;232(3):262\u2013270.e1. https:\/\/doi.org\/10.1016\/j.ajog.2024.10.054","DOI":"10.1016\/j.ajog.2024.10.054"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Miller R. Implementing a survivorship care plan for patients with breast cancer. Clin J Oncol Nurs. 2008;12(3):479\u2013487. https:\/\/doi.org\/10.1188\/08.CJON.479-487","DOI":"10.1188\/08.CJON.479-487"}],"container-title":["South African Family Practice"],"original-title":[],"link":[{"URL":"https:\/\/safpj.co.za\/index.php\/safpj\/article\/viewFile\/6200\/9900","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/safpj.co.za\/index.php\/safpj\/article\/viewFile\/6200\/9901","content-type":"application\/epub+zip","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/safpj.co.za\/index.php\/safpj\/article\/viewFile\/6200\/9902","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/safpj.co.za\/index.php\/safpj\/article\/viewFile\/6200\/9903","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/safpj.co.za\/index.php\/safpj\/article\/view\/6200\/9903","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:37:10Z","timestamp":1769603830000},"score":1,"resource":{"primary":{"URL":"https:\/\/safpj.co.za\/index.php\/safpj\/article\/view\/6200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":30,"aliases":["10.4102\/safp.v67i2.6200"],"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.4102\/safp.v68i1.6200","relation":{},"ISSN":["2078-6190","2078-6204"],"issn-type":[{"value":"2078-6190","type":"print"},{"value":"2078-6204","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"article-number":"a6200"}}